214 related articles for article (PubMed ID: 37296423)
1. Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study.
Cooper L; Rosen JG; Zhang L; Pelaez D; Olatunde PF; Owczarzak J; Park JN; Glick JL
Harm Reduct J; 2023 Jun; 20(1):71. PubMed ID: 37296423
[TBL] [Abstract][Full Text] [Related]
2. Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland.
Patel EU; Grieb SM; Winiker AK; Ching J; Schluth CG; Mehta SH; Kirk GD; Genberg BL
Harm Reduct J; 2024 May; 21(1):91. PubMed ID: 38720307
[TBL] [Abstract][Full Text] [Related]
3. Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study.
Rosen JG; Zhang L; Pelaez D; Coleman JS; To C; Cooper L; Olatunde PF; Toomre T; Glick JL; Park JN
AIDS Patient Care STDS; 2022 Aug; 36(8):313-320. PubMed ID: 35951445
[TBL] [Abstract][Full Text] [Related]
4. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives.
May T; Dawes J; Fancourt D; Burton A
Int J Drug Policy; 2022 Aug; 106():103752. PubMed ID: 35653821
[TBL] [Abstract][Full Text] [Related]
5. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 on essential healthcare services at the primary healthcare level in Armenia: a qualitative study.
Hayrumyan V; Abrahamyan A; Harutyunyan A; Libaridian L; Sahakyan S
BMC Prim Care; 2024 Apr; 25(1):131. PubMed ID: 38658818
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 on substance use disorder treatment services in Kenya: Qualitative findings from healthcare providers.
Muller A; Akiyama MJ; Riback L; Nyakowa M; Musyoki H; Cherutich P; Kurth A
Int J Drug Policy; 2022 Jul; 105():103710. PubMed ID: 35580533
[TBL] [Abstract][Full Text] [Related]
8. Client and Clinician Experiences and Perspectives of Exercise Physiology Services During the COVID-19 Pandemic: Qualitative Study.
Brown RCC; Keating SE; Owen PJ; Jansons PS; McVicar J; Askew CD; Clanchy KM; Maddison R; Maiorana A; Robinson SM; Mundell NL
J Med Internet Res; 2023 Dec; 25():e46370. PubMed ID: 38127430
[TBL] [Abstract][Full Text] [Related]
9. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
[TBL] [Abstract][Full Text] [Related]
10. Impact of VA's video telehealth tablets on substance use disorder care during the COVID-19 pandemic.
Gujral K; Van Campen J; Jacobs J; Kimerling R; Zulman DM; Blonigen D
J Subst Use Addict Treat; 2023 Jul; 150():209067. PubMed ID: 37164153
[TBL] [Abstract][Full Text] [Related]
11. Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outpatient treatment program.
Sadicario JS; Parlier-Ahmad AB; Brechbiel JK; Islam LZ; Martin CE
J Subst Abuse Treat; 2021 Mar; 122():108200. PubMed ID: 33250270
[TBL] [Abstract][Full Text] [Related]
12. Lived experiences of frontline healthcare providers offering maternal and newborn services amidst the novel corona virus disease 19 pandemic in Uganda: A qualitative study.
Kayiga H; Genevive DA; Amuge PM; Ssemata AS; Nanzira RS; Nakimuli A
PLoS One; 2021; 16(12):e0259835. PubMed ID: 34890417
[TBL] [Abstract][Full Text] [Related]
13. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States.
Lin C; Pham H; Zhu Y; Clingan SE; Lin LA; Murphy SM; Campbell CI; Sorrell TR; Liu Y; Mooney LJ; Hser YI
Drug Alcohol Depend; 2023 Jan; 242():109711. PubMed ID: 36462230
[TBL] [Abstract][Full Text] [Related]
14. Health worker perceptions of the impact of COVID-19 on harm reduction services for people who inject drugs.
Brener L; Horwitz R; Rance J; Caruana T; Bryant J
Health Soc Care Community; 2022 Nov; 30(6):2320-2329. PubMed ID: 35293054
[TBL] [Abstract][Full Text] [Related]
15. Midwife-led pandemic telemedicine services for maternal health and gender-based violence screening in Bangladesh: an implementation research case study.
Islam A; Begum F; Williams A; Basri R; Ara R; Anderson R
Reprod Health; 2023 Aug; 20(1):128. PubMed ID: 37644451
[TBL] [Abstract][Full Text] [Related]
16. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
[TBL] [Abstract][Full Text] [Related]
17. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
[TBL] [Abstract][Full Text] [Related]
18. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
[TBL] [Abstract][Full Text] [Related]
19. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
20. HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives.
McCrimmon T; Sundelson A; Darisheva M; Gilbert L; Hunt T; Terlikbayeva A; Primbetova S; El-Bassel N
Glob Health Sci Pract; 2022 Apr; 10(2):. PubMed ID: 35487549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
